![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 6, 4532-4543, February 11, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







¶
From the
Department of Pharmacology and Neurosciences and
Department of Anatomy, KEIO University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
AlsinLF, the product of the ALS2 gene, inhibits Cu/Zn-superoxide dismutase (SOD1) mutant-induced neurotoxicity via its Rho guanine nucleotide-exchanging factor domain. We here identified Rac1, a Rho family small GTPase, as a target for the Rho guanine nucleotide-exchanging factor activity of alsinLF. Rac1 associates with alsinLF. The amount of the GTP form of Rac1 is up-regulated by enforced overexpression of alsinLF. We further found not only that constitutively active Rac1 suppresses motoneuronal cell death induced by SOD1 mutants but also that the neuroprotective activity of alsinLF was completely inhibited by knocking down the endogenous Rac1 expression with small interfering RNA for Rac1, indicating that Rac1 is the major effector for alsinLF-mediated neuroprotection. Such alsinLF/Rac1-mediated neuroprotection occurs specifically against the SOD1 mutant-induced cell death but not against the cell death induced by any other neurotoxic insults in motoneuronal NSC34 cells. We further demonstrated that the alsinLF/Rac1-mediated neuroprotective signal is transmitted to the phosphatidylinositol 3-kinase/Akt anti-apoptotic axis. Among three Akt family proteins, Akt3 is the major downstream mediator for alsinLF/Rac1-mediated neuroprotection, which is specifically effective against SOD1 mutant-induced neurotoxicity.
Received for publication, September 13, 2004 , and in revised form, November 26, 2004.
* This work was supported in part by a grant-in-aid for encouragement of young medical scientists from Keio University (to K. K.), a grant from the Takeda Medical Research Foundation (to Y. H.), a grant-in-aid for scientific research on priority areas, and a grant from the Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Pharmacology, KEIO University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan. Tel.: 81-3-5363-3751; Fax: 81-3-3359-8889; E-mail: sakimatu{at}sc.itc.keio.ac.jp.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Donald, T. Humby, I. Fyfe, A. Segonds-Pichon, S. A. Walker, S. R. Andrews, W. J. Coadwell, P. Emson, L. S. Wilkinson, and H. C. E. Welch P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination PNAS, March 18, 2008; 105(11): 4483 - 4488. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-X. Deng, H. Zhai, R. Fu, Y. Shi, G. H. Gorrie, Y. Yang, E. Liu, M. C. Dal Canto, E. Mugnaini, and T. Siddique Distal axonopathy in an alsin-deficient mouse model Hum. Mol. Genet., December 1, 2007; 16(23): 2911 - 2920. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kunita, A. Otomo, H. Mizumura, K. Suzuki-Utsunomiya, S. Hadano, and J.-E Ikeda The Rab5 Activator ALS2/alsin Acts as a Novel Rac1 Effector through Rac1-activated Endocytosis J. Biol. Chem., June 1, 2007; 282(22): 16599 - 16611. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kanekura, I. Nishimoto, S. Aiso, and M. Matsuoka Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8) J. Biol. Chem., October 6, 2006; 281(40): 30223 - 30233. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Panzeri, C. De Palma, A. Martinuzzi, A. Daga, G. De Polo, N. Bresolin, C. C. Miller, E. L. Tudor, E. Clementi, and M. T. Bassi The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function Brain, July 1, 2006; 129(7): 1710 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Devon, P. C. Orban, K. Gerrow, M. A. Barbieri, C. Schwab, L. P. Cao, J. R. Helm, N. Bissada, R. Cruz-Aguado, T.-L. Davidson, et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities PNAS, June 20, 2006; 103(25): 9595 - 9600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gentile, T. Darden, C. Erxleben, C. Romeo, A. Russo, N. Martin, S. Rossie, and D. L. Armstrong Rac GTPase signaling through the PP5 protein phosphatase PNAS, March 28, 2006; 103(13): 5202 - 5206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Belmonte, M. F. Santos, A. H. Kihara, C. Y. I. Yan, and D. E. Hamassaki Light-Induced Photoreceptor Degeneration in the Mouse Involves Activation of the Small GTPase Rac1. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1193 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamamoto, M. L. Cremona, and J. E. Rothman Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway J. Cell Biol., February 27, 2006; 172(5): 719 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hadano, S. C. Benn, S. Kakuta, A. Otomo, K. Sudo, R. Kunita, K. Suzuki-Utsunomiya, H. Mizumura, J. M. Shefner, G. A. Cox, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking Hum. Mol. Genet., January 15, 2006; 15(2): 233 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Tudor, M. S. Perkinton, A. Schmidt, S. Ackerley, J. Brownlees, N. J. O. Jacobsen, H. L. Byers, M. Ward, A. Hall, P. N. Leigh, et al. ALS2/Alsin Regulates Rac-PAK Signaling and Neurite Outgrowth J. Biol. Chem., October 14, 2005; 280(41): 34735 - 34740. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai, X. Lin, C. Xie, F. M. Laird, C. Lai, H. Wen, H.-C. Chiang, H. Shim, M. H. Farah, A. Hoke, et al. Loss of ALS2 Function Is Insufficient to Trigger Motor Neuron Degeneration in Knock-Out Mice But Predisposes Neurons to Oxidative Stress J. Neurosci., August 17, 2005; 25(33): 7567 - 7574. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |